Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry

被引：66

作者：

Murata, Nobuhiro ^{[1
]}

Okumura, Yasuo ^{[1
]}

Yokoyama, Katsuaki ^{[2
]}

Matsumoto, Naoya ^{[2
]}

Tachibana, Eizo ^{[3
]}

Kuronuma, Keiichiro ^{[3
]}

Oiwa, Koji ^{[4
]}

Matsumoto, Michiaki ^{[4
]}

Kojima, Toshiaki ^{[5
]}

Hanada, Shoji ^{[6
]}

Nomoto, Kazumiki ^{[7
]}

Arima, Ken ^{[8
]}

Takahashi, Fumiyuki ^{[9
]}

Kotani, Tomobumi ^{[10
]}

Ikeya, Yukitoshi ^{[11
]}

Fukushima, Seiji ^{[12
]}

Itoh, Satoru ^{[13
]}

Kondo, Kunio ^{[14
]}

Chiku, Masaaki ^{[15
]}

Ohno, Yasumi ^{[16
]}

Onikura, Motoyuki ^{[17
]}

Hirayama, Atsushi ^{[1
]}

Hirayama, A. ^{[18
,19
]}

Okumura, Y. ^{[18
]}

Kunimoto, S. ^{[18
]}

Okumura, Y. ^{[18
]}

Kato, M. ^{[18
]}

Udagawa, S. ^{[19
]}

Hirayama, A. ^{[18
,19
]}

Okumura, Y. ^{[18
]}

Watanabe, I ^{[18
]}

Hiro, T. ^{[18
]}

Takayama, T. ^{[18
]}

Kunimoto, S. ^{[18
]}

Nakai, T. ^{[18
]}

Kato, M. ^{[18
]}

Yokoyama, K. ^{[2
]}

Ikeda, A. ^{[2
]}

Matsumoto, N. ^{[2
]}

Tachibana, E. ^{[3
]}

Kuronuma, K. ^{[3
]}

Oiwa, K. ^{[4
]}

Matsumoto, M. ^{[4
]}

Nishida, T. ^{[4
]}

Kojima, T. ^{[5
]}

Ichikawa, M. ^{[5
]}

Hanada, S. ^{[20
]}

Nomoto, K. ^{[7
]}

Tosaka, T. ^{[7
]}

Sonoda, K. ^{[7
]}

机构：

[1] Nihon Univ, Itabashi Hosp, Div Cardiol, Tokyo, Japan

[2] Nihon Univ Hosp, Dept Cardiol, Tokyo, Japan

[3] Kawaguchi Municipal Med Ctr, Saitama, Japan

[4] Yokohama Chuo Hosp, Yokohama, Kanagawa, Japan

[5] Sekishindo Hosp, Saitama, Japan

[6] TMG Asaka Med Ctr, Saitama, Japan

[7] Tokyo Rinkai Hosp, Tokyo, Japan

[8] Kasukabe Med Ctr, Saitama, Japan

[9] Yasuda Hosp, Tokyo, Japan

[10] Makita Gen Hosp, Tokyo, Japan

[11] Itabashi Med Assoc Hosp, Tokyo, Japan

[12] Ukima Cent Hosp, Tokyo, Japan

[13] Itou Cardiovasc Clin, Saitama, Japan

[14] Kondo Clin, Tokyo, Japan

[15] Keiai Clin, Tokyo, Japan

[16] Ohno Med Clin, Tokyo, Japan

[17] Onikura Clin, Chiba, Japan

[18] Nihon Univ, Div Cardiol, Dept Med, Sch Med, Tokyo, Japan

[19] Nihon Univ, Dept Math, Sch Med, Tokyo, Japan

[20] Asakadai Cent Gen Hosp, Asaka, Saitama, Japan

[21] Kasukabe Municipal Hosp, Kasukabe, Saitama, Japan

[22] Kobari Gen Clin, Noda, Chiba, Japan

[23] Chikuma Cent Hosp, Nagano, Japan

[24] Yamada Clin, Nishio, Aichi, Japan

[25] Higashi Saitama Gen Hosp, Satte, Saitama, Japan

[26] Zengyodanchi Ishikawa Clin, Yokohama, Kanagawa, Japan

[27] Tokutake Clin, Saitama, Japan

[28] Sugino Clin, Hiroshima, Japan

[29] Yokohama Sotetsu Bldg Clin, Yokohama, Kanagawa, Japan

[30] Suzuki Clin, Tokyo, Japan

[31] Fujita Clin, Tokyo, Japan

[32] Yumikura Clin, Tokyo, Japan

[33] Keiai Hosp, Fujimi, Saitama, Japan

[34] Sekimachi Med Clin, Tokyo, Japan

[35] Tokiwadai Surg Hosp, Tokyo, Japan

[36] Hikarigaoka Clin, Kashiwa, Chiba, Japan

[37] Osuga Clin, Hamamatsu, Shizuoka, Japan

[38] Nakai Clin, Tokyo, Japan

[39] Kurumatani Clin, Tokyo, Japan

[40] Horinaka Hosp, Satte, Saitama, Japan

[41] Nasu Red Cross Hosp, Otawara, Tochigi, Japan

[42] Sato Clin, Hiroshima, Japan

[43] Kofune Clin, Tokyo, Japan

[44] Ikebukuro Okubo Clin, Tokyo, Japan

[45] Minami Machida Hosp, Machida, Tokyo, Japan

[46] Ishii Clin, Izumisano, Osaka, Japan

[47] Akabane Cent Hosp, Tokyo, Japan

[48] Hirose Clin, Suzuka, Mie, Japan

[49] Sekimoto Mem Hosp, Kawagoe, Saitama, Japan

[50] Matsumura Clin, Hirakata, Osaka, Japan

来源：

CIRCULATION JOURNAL | 2019年 / 83卷 / 04期

关键词：

Atrial fibrillation; Direct oral anticoagulants; Off-label dose therapy; ISCHEMIC-STROKE; VS; WARFARIN; RISK; RIVAROXABAN; DABIGATRAN; APIXABAN; EDOXABAN; EFFICACY; SAFETY;

D O I：

10.1253/circj.CJ-18-0991

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Off-label dosing of direct oral anticoagulants (DOACs) is encountered clinically among patients with atrial fibrillation (AF), although data on the clinical outcomes of over-and under-dosing are lacking in Japan. Methods and Results: We examined the clinical outcomes of off-label DOAC dosing using the SAKURA AF Registry, a prospective multicenter registry in Japan. Among 3,237 enrollees, 1,676 under any of the 4 DOAC regimens were followed up for a median of 39.3 months: 746 (45.0%), appropriate standard-dose; 477 (28.7%), appropriate low-dose; 66 (4.0%), over-dose; and 369 (22.2%) under-dose. Compared with the standard-dose group, patients in the under-and over-dose groups were significantly older and had a higher stroke risk. After multivariate adjustment, stroke/systemic embolism (SE) and death events were equivalent between the standard-and under-dose groups, but major bleeding events tended to be lower in the under-dose group (hazard ratio [HR] 0.474, P=0.0739). Composite events (stroke/SE, major bleeding, or death) were higher in the over-dose than in the standard-dose group (HR 2.714, P=0.0081). Conclusions: Clinical outcomes were not worse for under-dose than for standard-dose users among patients with different backgrounds. Over-dose users, however, were at higher risk for all clinical events and required careful follow-up. Further studies are needed to clarify the safety and effectiveness of off-label DOAC dosing in Japan.

引用

页码：727 / +

页数：11

共 50 条

[21] Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose
Xu, Wenlin
Lv, Meina
Wu, Tingting
Huang, Nianxu
Zhang, Wang
Su, Jun
Dai, Hengfen
Gu, Ping
Huang, Xiaohong
Du, Xiaoming
Li, Ruijuan
Zheng, Qiaowei
Lin, Xiangsheng
Liu, Yuxin
Zhang, Min
Liu, Xiumei
Zhu, Zhu
Zhang, Jinhua
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 371 : 184 - 190
[22] The combination therapy with oral anticoagulant and antiplatelet drug for atrial fibrillation patients: the Fushimi AF Registry
Masunaga, N.
Iguchi, M.
Ishii, M.
Esato, M.
Chun, Y. H.
Wada, H.
Hasegawa, K.
Ogawa, H.
Abe, M.
Akao, M.
EUROPEAN HEART JOURNAL, 2016, 37 : 502 - 502
[23] Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients
Kwang-No Lee
Jong-Il Choi
Ki Yung Boo
Do Young Kim
Yun Gi Kim
Suk-Kyu Oh
Yong-Soo Baek
Dae In Lee
Seung-Young Roh
Jaemin Shim
Jin Seok Kim
Young-Hoon Kim
Scientific Reports, 10
[24] Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation
Rymer, Jennifer A.
Chiswell, Karen
Young, Lauren
Chiu, Andy
Liu, Li
Webb, Laura
Carlisle, Matthew
Friedman, Daniel
Wang, Tracy Y.
JAMA NETWORK OPEN, 2023, 6 (06)
[25] Adverse clinical events in Japanese atrial fibrillation patients with and without coronary artery disease-findings from the SAKURA AF Registry
Fukamachi, Daisuke
Okumura, Yasuo
Yokoyama, Katsuaki
Matsumoto, Naoya
Tachibana, Eizo
Kuronuma, Keiichiro
Oiwa, Koji
Matsumoto, Michiaki
Nishida, Toshihiko
Kojima, Toshiaki
Hanada, Shoji
Nomoto, Kazumiki
Sonoda, Kazumasa
Arima, Ken
Kogawa, Rikitake
Takahashi, Fumiyuki
Kotan, Tomobumi
Ohkubo, Kimie
Fukushima, Seiji
Itou, Satoru
Kondo, Kunio
Chiku, Masaaki
Ohno, Yasumi
Onikura, Motoyuki
Hirayama, Atsushi
CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) : 2053 - 2062
[26] Reply: How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
Kino, Tabito
Nogami, Akihiko
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025,
[27] Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients - Fushimi AF Registry
Yamashita, Yugo
Uozumi, Ryuji
Hamatani, Yasuhiro
Esato, Masahiro
Chun, Yeong-Hwa
Tsuji, Hikari
Wada, Hiromichi
Hasegawa, Koji
Ogawa, Hisashi
Abe, Mitsuru
Morita, Satoshi
Akao, Masaharu
CIRCULATION JOURNAL, 2017, 81 (09) : 1278 - +
[28] The Characteristics and Outcomes of the Elderly Atrial Fibrillation Patients With or Without Oral Anticoagulants in Japanese Clinical Practice: The Fushimi AF Registry
Ikeda, Syuhei
Iguchi, Moritake
Aono, Yuya
Doi, Kosuke
An, Yoshimori
Ishii, Mitsuru
Masunaga, Nobutoyo
Esato, Masahiro
Wada, Hiromichi
Hasegawa, Koji
Ogawa, Hisashi
Abe, Mitsuru
Akao, Masaharu
CIRCULATION, 2018, 138
[29] Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry
Iso, Kazuki
Nagashima, Koichi
Arai, Masaru
Watanabe, Ryuta
Yokoyama, Katsuaki
Matsumoto, Naoya
Otsuka, Takayuki
Suzuki, Shinya
Hirata, Akio
Murakami, Masato
Takami, Mitsuru
Kimura, Masaomi
Fukaya, Hidehira
Nakahara, Shiro
Kato, Takeshi
Hayashi, Hiroshi
Iwasaki, Yu-ki
Shimizu, Wataru
Nakajima, Ikutaro
Harada, Tomoo
Koyama, Junjiroh
Okumura, Ken
Tokuda, Michifumi
Yamane, Teiichi
Tanimoto, Kojiro
Momiyama, Yukihiko
Nonoguchi, Noriko
Soejima, Kyoko
Ejima, Koichiro
Hagiwara, Nobuhisa
Harada, Masahide
Sonoda, Kazumasa
Inoue, Masaru
Kumagai, Koji
Hayashi, Hidemori
Yazaki, Yoshinao
Satomi, Kazuhiro
Watari, Yuji
Okumura, Yasuo
HEART AND VESSELS, 2021, 36 (04) : 549 - 560
[30] Effectiveness and Safety of Off-label Dosing of Non-vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients
Lee, Kwang-No
Choi, Jong-Il
Boo, Ki Yung
Kim, Do Young
Kim, Yun Gi
Oh, Suk-Kyu
Baek, Yong-Soo
Lee, Dae In
Roh, Seung-Young
Shim, Jaemin
Kim, Jin Seok
Kim, Young-Hoon
SCIENTIFIC REPORTS, 2020, 10 (01)

← 1 2 3 4 5 →